Better Buy: Novo Nordisk vs. Eli Lilly | The Motley Fool

While Ozemipc is the brand name on everyone's lips when they talk about weight loss, it's only approved to control blood sugar and reduce the risk of heart attacks for patients with type 2 diabetes. Nevertheless, … See more

CouponFollow Extension

24%
OFF

Better Buy: Eli Lilly Vs. Novo Nordisk. The Answer Is Becoming ...

3 weeks from now

Dec 26, 2024 · Enter Eli Lilly (LLY-0.24%) and Novo Nordisk (NVO 0.34%), the makers behind blockbuster glucagon-like peptide-1 (GLP-1) agonists such as Mounjaro, Zepbound, Ozempic, …

fool.com

32%
OFF

Better Buy: Eli Lilly Or Novo Nordisk? | The Motley Fool

3 weeks from now

Dec 23, 2024 · In this video, I will cover the recent updates regarding Novo Nordisk (NVO-0.32%) and whether or not the dip is worth buying over Eli Lilly (LLY-1.38%). Watch the short video to …

fool.com

32%
OFF

Better Growth Stock: Novo Nordisk Vs. Eli Lilly | The Motley Fool

3 weeks from now

Nov 16, 2023 · It's difficult to find a pair of biotech giants that have performed better than Novo Nordisk (NVO 0.32%) and Eli Lilly (LLY-0.19%) this year. Both have left broader equities well …

fool.com

88%
OFF

Better Blockbuster-Drug Stock: Novo Nordisk Vs. Eli Lilly

3 weeks from now

Mar 3, 2024 · Novo Nordisk (NVO-1.88%) and Eli Lilly (LLY-1.19%) are two of the hottest pharmaceutical stocks of the past three years. Both companies have marked returns far in …

fool.com

24%
OFF

These 3 Factors Could Make Eli Lilly Stock A Better Buy Than Novo ...

3 weeks from now

Aug 31, 2024 · Eli Lilly (LLY-0.24%) and Novo Nordisk (NVO 0.34%) are big pharma peers. They're also each other's biggest rivals, especially in the all-important market for weight-loss …

fool.com

34%
OFF

Why Novo Nordisk Stock Got Destroyed Today, But Eli ... - The …

3 weeks from now

Dec 20, 2024 · Bad news for Novo Nordisk (NVO 0.34%) Friday was good news for Eli Lilly (LLY-0.24%) and Viking Therapeutics (VKTX 1.18%), its two main rivals in the field of weight loss …

fool.com

79%
OFF

2 Pharmaceutical Growth Stocks To Buy Now And Hold For Decades

3 weeks from now

Dec 28, 2024 · Eli Lilly (LLY 0.79%) and Novo Nordisk (NVO 1.74%) have attracted a lot of attention over the past two years thanks to their advances in the weight loss therapy market. …

fool.com

20%
OFF

Does This News From The FDA Make Eli Lilly A Buy For 2025?

3 weeks from now

Dec 23, 2024 · In a recent head-to-head study involving Novo Nordisk's Wegovy, Zepbound came out on top, resulting in average weight loss of about 20%, compared to more than 13% for the …

fool.com

19%
OFF

Down 19% In 1 Day, Is Novo Nordisk Stock Still A Buy?

3 weeks from now

Dec 26, 2024 · In contrast, per a different phase 3 study investigating a competing weight loss drug, Eli Lilly's (LLY-0.24%) Zepbound, patients treated with the highest dose lost 20.9% of …

fool.com

FAQs about Better Buy: Novo Nordisk vs. Eli Lilly | The Motley Fool Coupon?

Should I buy Novo Nordisk or Eli Lilly?

While Eli Lilly is the stock I'd rather own right now, a relatively modest valuation makes Novo Nordisk the better buy. Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Pfizer. The Motley Fool recommends Johnson & Johnson and Novo Nordisk. ...

Are Novo Nordisk and Eli Lilly the hottest pharmaceutical stocks?

Novo Nordisk ( NVO 2.34%) and Eli Lilly ( LLY 0.13%) are two of the hottest pharmaceutical stocks of the past three years. Both companies have marked returns far in excess of the market's, thanks to popular demand for their freshly launched medications that treat obesity as well as type 2 diabetes. ...

Should you buy Novo Nordisk to take advantage of soaring weight-management sales?

Before buying Novo Nordisk stock to take advantage of soaring weight-management sales, you should know that Eli Lilly (LLY -3.68%) has a weight-management program too. Some analysts think Mounjaro, a diabetes treatment from Eli Lilly, could become an even bigger weight-management drug than Novo Nordisk's. ...

Are Eli Lilly & Novo Nordisk rivals?

This competitive showdown just saw one of the players hit a couple of bumps. Eli Lilly (LLY -0.13%) and Novo Nordisk (NVO 0.33%) are big pharma peers. They're also each other's biggest rivals, especially in the all-important market for weight-loss drugs, in which both are currently highly successful. ...

Is Novo Nordisk a good stock to buy now?

While Novo Nordisk is probably the better weight-management stock, a more diverse product lineup and development pipeline make Eli Lilly the better overall pharmaceutical business. A more reasonable valuation makes me want to call Novo Nordisk the better buy now, but that probably isn't the best course of action. ...

Should investors invest in Eli Lilly & Novo Nordisk?

That means investors will have plenty of catalysts to possibly power outsized returns if things go as planned with the Food and Drug Administration (FDA). Much like Novo Nordisk, Eli Lilly's pipeline is chock-full of near-term opportunities to launch winning therapies, and it has a few strong performers in hand as well. ...